Menu

Use of levosimendan in different settings - Efficacy and safety

Webcasts word

COMING WEBCASTS

SAVE THE DATE: on Wednesday, March 21st at 18:15 - 18:55 live from the 38th ISICEM

LEVOSIMENDAN IN PERIOPERATIVE ENVIRONMENT: EFFICACY AND SAFETY

Chair: Prof. Fabio Guarracino, MD, PhD, President EACTA (Pisa, Italy)

Topics and speakers:

18:15-18:30 “Perioperative effects of levosimendan in CABG

Prof. Matthias Heringlake (Lübeck, Germany)

18:30-18.45 “Renal effects of levosimendan

Prof. Sven-Erik Ricksten (Gothenburg, Sweden)

18:45-18:55 Panel debate and Q&A session

LEARNING OBJECTIVES FOR THIS WEBCAST

• The attendee will learn the effects of levosimendan when used in CABG peri-operative settings, its safety
and efficacy. New data from the sub-analysis of the LEVO-CTS trial in low ejection fraction and in the
CABG settings will be disclosed and discussed.

• The attendee will learn the renal effects of levosimendan in acute cardiac settings. New data on the effect
of levosimendan on glomerular filtration will be presented and discussed (the ELDOR clinical trial).

ABOUT THE FACULTY
Fabio Guarracino photo
Fabio Guarracino (Pisa, Italy)
Head of the Department of Anesthesia and Critical Care Medicine and Director of Cardiothoracic Anesthesia and Intensive Care at Azienda Ospedaliero Universitaria in Pisa, Italy. Active member of ESICM, ESA, EACTA, EACVI, SCA, SIAARTI. Board member of the Journal of Cardiothoracic and Vascular Anesthesia, and other journals. Main research interests are in echo-cardiography, acute heart failure and the design of intensive care pathways to improve the effectiveness of the patient journey.

Matthias Heringlake photo
Matthias Heringlake (Lubeck, Germany)
Professor of Anesthesiology and Deputy Director of Cardiothoracic Anesthesia at the Department of Anesthesiology and Intensive Care Medicine, University of Lubeck. He is German Representative of EACTA since 2014. He has published over 100 PubMed listed papers in the field of anesthesia and intensive care therapy with a focus on vasoactive drugs and monitoring, and has participated as co-investigator in the recent LEVO-CTS trial.

Sven-Erik Ricksten photo
Sven-Erik Ricksten (Gotenburg, Sweden)
Professor and Academic Chair of the Department of Anaesthesiology and Intensive Care Medicine and Consultant in Cardiothoracic Anaesthesia and Intensive Care at Sahlgrenska University Hospital, Gothenburg, Sweden. In his career he published over 150 original scientific articles and received several awards, such as the Konrad and Helfrid Johanssons award for young investigators;  He received multiple national and international research and education grants and is currently running multiple clinical trials.

Pre-registration site opens soon, keep following this page for updates.

***

PAST WEBCASTS

Visit this page to view programs and recordings of the past webcasts.